Leili Chamani-Tabriz
Iranian Hospital, UAE
Scientific Tracks Abstracts: J AIDS Clin Res
Syphilis is a sexually transmitted disease caused by the spirochete Treponema pallidum. Every year many patients are diagnosed and treated for this infection. Patients may be totally asymptomatic discovered during routine screening tests or present with various types of manifestations mimicking a lot of other disorders based on the stage of infection including primary, secondary or tertiary infection. Serologic tests provide a presumptive diagnosis of syphilis. There are two types of serologic tests for syphilis: non-Treponemal tests and Treponemal-specific tests. The most challenging steps are coming afterwards for interpretation of serologic testing and treatment selection. A lot of factors including history of drug reaction, pregnancy, HIV status, and history of previous treatment, possibility of CNS involvement and stage of the infection would be effective on the decision about treatment and follow up. There are different guidelines on treatment which should be used promptly, also follow up would be challenging as a lot of patients are considered non-responder and receive multiple cycles of treatment while there may be another explanation for their serologic status. The course and route of treatment is so different based on the stage of diseases and patients manifestations so there is no one prescription suitable for all patients. Penicillin has been the best choice for all stages of syphilis management. But the dose and route of administration would be different for early syphilis the standard treatment would be Penicillin G benzathine 2.4 million units IM once, in late syphilis Penicillin G benzathine 2.4 million units IM once weekly for three weeks is proposed and for neurosyphilis treatment aqueous penicillin G 3 to 4 million units IV every four hours for 10 to 14 days is advised. In this session we are going to have a look on the practical approach to a patient with syphilis to provide the best diagnosis and most effective treatment.
Leili Chamani-Tabriz has strong professional background as a Doctor of Medicine, MD, board certified specialist focused in infectious diseases and tropical medicine since 2000 after graduating from Shahid Beheshti Medical University, Tehran and joined to Iranian Hospital Dubai in 2012. She started to run the first Reproductive Infections research group in Avicenna Research Institute and first reproductive health clinic in Avicenna Infertility Clinic in Tehran, Iran. She has strong background in medical education, clinical practice and research with published articles in national and international journals with active presence in conferences and also run multiple national and international research projects and workshops. She is a Member of UAE National Antimicrobial Stewardship program, Fungal Infections study group and Molecular Diagnostic study group of ESCMID (European Society of Clinical Microbiology and Infectious Diseases). Her main research interests are reproductive infections, medical mycology and antimicrobial resistance.
E-mail: lchamani@gmail.com
Journal of AIDS & Clinical Research received 5061 citations as per Google Scholar report